Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Assets | $ 260.52M | $ 252.31M | $ 229.74M | $ 200.83M | $ 191.28M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 67.43M | $ 61.21M | $ 55.45M | $ 43.75M | $ 44.05M |
Stockholders Equity | $ 193.09M | $ 191.10M | $ 174.29M | $ 157.08M | $ 147.24M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |